Skip to main content

Bausch Health plans $1.21B settlement over plunging stock

By Fox Business  
   December 17, 2019

Bausch Health, once known as Valeant Pharmaceuticals, will pay more than $1 billion to settle litigation over a stock plunge that investors suffered after it became the poster child of drug company price gouging several years ago.

Full story

Get the latest on healthcare leadership in your inbox.